Position
Chief Financial Officer
Company
Candel Therapeutics
NeedhamBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Candel Therapeutics announces the promotion of Charles Schoch from interim CFO to permanent Chief Financial Officer. This appointment is effective immediately, reflecting Mr. Schoch's exceptional financial leadership and support for the company's strategic priorities.
Quick answer
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer (June 23, 2025). Candel Therapeutics is based in Needham, Massachusetts, United States.
- Who is the new Chief Financial Officer at Candel Therapeutics?
- Candel Therapeutics named Charles Schoch Chief Financial Officer, announced June 23, 2025.
- What did Candel Therapeutics announce on June 23, 2025?
- Candel Therapeutics announces the promotion of Charles Schoch from interim CFO to permanent Chief Financial Officer. This appointment is effective immediately, reflecting Mr. Schoch's exceptional financial leadership and support for the company's strategic priorities.
- What does Candel Therapeutics do?
- Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer.
- Where is Candel Therapeutics based?
- Candel Therapeutics is based in Needham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- OnCusp Therapeutics (June 23, 2025), Alnylam Pharmaceuticals (June 19, 2025), ISOThrive (July 2, 2025) and Jazz Pharmaceuticals plc (July 10, 2025) also announced leadership changes within 45 days of Candel Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OnCusp Therapeutics Appoints Dimitry S.A. Nuyten as Chief Medical Officer (June 23, 2025)
- Alnylam Pharmaceuticals Appoints Pushkal Garg as Chief Research and Development Officer (June 19, 2025)
- ISOThrive Inc. Appoints Mike Walther as Chief Strategy Officer (July 2, 2025)
- Jazz Pharmaceuticals Appoints Renee Gala as Chief Executive Officer (July 10, 2025)
- Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President (May 27, 2025)
- CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer (July 21, 2025)
Who to call at Candel Therapeutics, and when
A new leader at Candel Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Candel Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Candel Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Candel Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Candel Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Candel Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.